Raaj Medisafe India Ltd (RAAJMEDI) — shareholding pattern, promoter holding, financials and share price
About Raaj Medisafe India Ltd (RAAJMEDI)
Raaj Medisafe India Ltd operates in the Packaging industry, within the Capital Goods sector. It trades on the NSE as RAAJMEDI and on the BSE under scrip code 524502. Its ISIN is INE548H01015.
Incorporated in 1985, Raaj Medisafe India Ltd manufactures plastic bottles, caps & plugs, plastic liners, aluminum caps, Sanitary Napkins and Diaper. [1]
Raaj Medisafe India Limited, initially known as Manoj Surgical Industries Limited, focuses on manufacturing medical disposable devices, including plastic bottles, caps, plugs, liners, and aluminum caps.
The company's modern manufacturing facility is located in Pithampur, conforming to cGMP requirements, showcasing its commitment to high-quality standards.
Listed peers in Packaging: Mega Flex Plastics Ltd, Srivasavi Adhesive Tapes Ltd, Hindustan Tin Works Ltd, Ideal Technoplast Industries Ltd, Gujarat Containers Ltd, Clara Industries Ltd.
Valuation & Returns
At ₹74.6 a share, Raaj Medisafe India Ltd (RAAJMEDI) was valued at a price-to-earnings ratio of 63.03x against an industry P/E of 37x and a price-to-book of 2.49x on a book value of ₹28.46 per share. Solomo computes return on equity of 3.87% and return on capital employed of 9.23% from filed results.
- P/E
- 63.03x
- Industry P/E
- 37x
- P/B
- 2.49x
- EPS (TTM)
- ₹1.92
- Book value / share
- ₹28.46
- ROE
- 3.87%
- ROCE
- 9.23%
- ROA
- 1.52%
- Debt / equity
- 1.37x
- Dividend yield
- 0%
- EBITDA margin
- 15.41%
- 52-week range
- ₹64.08 – ₹101.83
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Raaj Medisafe India Ltd (RAAJMEDI) reported revenue of ₹80.01 crore, net profit of ₹1.81 crore and earnings per share of ₹1.1. That compares with revenue of ₹62.42 crore and net profit of ₹6.13 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹25.08 crore and net profit ₹-3.23 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 34.68 | 38.61 | 43.24 | 62.42 | 80.01 |
| Net profit (₹ cr) | 3.01 | 3.33 | 3.33 | 6.13 | 1.81 |
| EPS (₹) | 2.75 | 3.04 | 3.04 | 4.64 | 1.1 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 48.32% | 23.42% | 21.62% | 44.32% |
| Profit growth | - | - | 26.72% | 84.08% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 59.08% of Raaj Medisafe India Ltd (RAAJMEDI) (down 14.72 pp QoQ). Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: Dinesh Patel 3.32%, Seema Patel 3.32%, GOVIND MAHESHWARI 2.78%, LIFEPULSE MEDTECH PRIVATE LIMITED 2.44%, RAMESH CHAND MAHESHVARI 1.95%, YASH RAMESH BRAHMBHATT 1.67%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 59.08% | - | - | - | 40.92% |
| Mar 2026 | 73.8% | - | - | - | 26.2% |
| Dec 2025 | 73.8% | - | - | - | 26.2% |
| Sep 2025 | 73.8% | - | - | - | 26.2% |
| Jun 2025 | 73.44% | - | - | - | 26.56% |
| Mar 2025 | 73.44% | - | - | - | 26.56% |
| Dec 2024 | 73.44% | - | - | - | 26.56% |
| Sep 2024 | 73.44% | - | - | - | 26.56% |